• National Yang-Ming University
• Institute of Clinical Medicine, National Yang-Ming University

• Attending physician, Division of Cardiology, Taipei Veterans General Hospital

• Professor, Faculty of medicine, National Yang Ming Chiao Tung University

• Resident training in Department of Medicine,  Taipei Veterans General Hospital 
• Chief resident and fellow training in Division of Cardiology, Taipei Veterans General Hospital

• License of physician, Taiwan

• Cardiac arrhythmia
• Permanent pacemaker implantation
• Implanted cardioverter defibrillator
• Cardiac resynchronization therapy

• tfchao@vghtpe.gov.tw

1. Chao TF, Lip GYH, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, Chen SA. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation. J Am Coll Cardiol 2018;71:122-132.

2. Chao TF, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, Lip GYH, Chen SA. Oral Anticoagulation in Very Elderly Patients with Atrial Fibrillation - A Nationwide Cohort Study. Circulation 2018;138:37-47.

3. Chao TF, Chen SA, Ruff CT, Hamershock RA, Mercuri MF, Antman EM, Braunwald E, Giugliano RP. Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial. Eur Heart J 2019;40:1518-1527.

4. Chao TF, Chiang CE, Chen TJ, Lip GYH, Chen SA. Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation. Ann Intern Med 2019;170:663-664.

5. Chao TF, Lip GYH, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, Chen SA. Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities. Eur Heart J 2019;40:1504-151

限於篇幅,以上謹為代表著作